Alexander F. Rosenberg

Prof. Alexander F. Rosenberg


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Frontiers in Immunology
Verified
Journal Article
Open access
DKDenise A. Kaminski
Denise A. Kaminski
CWChungwen Wei
Chungwen Wei
YQYu Qian
Yu Qian
ARAlexander F. Rosenberg
Alexander F. Rosenberg
ISIgnacio Sanz
Ignacio Sanz
To advance our understanding and treatment of disease, research immunologists have been called-upon to place more centralized emphasis on impactful human studies. Such endeavors will inevitably require large-scale study execution and data management regulation (“Big Biology”), necessitating standardized and reliable metrics of immune status and function. A well-known example setting this large-scale effort in-motion is identifying correlations between eventual disease outcome and T lymphocyte phenotype in large HIV-patient cohorts using multiparameter flow cytometry. However, infection, immunodeficiency, and autoimmunity are also characterized by correlative and functional contributions of B lymphocytes, which to-date have received much less attention in the human Big Biology enterprise. Here, we review progress in human B cell phenotyping, analysis, and bioinformatics tools that constitute valuable resources for the B cell research community to effectively join in this effort.

2 May 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
SGSwetha Garimalla
Swetha Garimalla
DNDoan C. Nguyen
Doan C. Nguyen
JHJessica L. Halliley
Jessica L. Halliley
CTChristopher Tipton
Christopher Tipton
ARAlexander F. Rosenberg
Alexander F. Rosenberg
FLF. Eun-Hyung Lee
F. Eun-Hyung Lee
Human antibody-secreting cells (ASCs) triggered by immunization are globally recognized as CD19 lo CD38 hi CD27 hi . Yet, different vaccines give rise to antibody responses of different longevity, suggesting ASC populations are heterogeneous. We define circulating-ASC heterogeneity in vaccine responses using multicolor flow cytometry, morphology, V H repertoire, and RNA transcriptome analysis. We also tested differential survival using a human cell-free system that mimics the bone marrow (BM) microniche. In peripheral blood, we identified 3 CD19 + and 2 CD19 – ASC subsets. All subsets contributed to the vaccine-specific responses and were characterized by in vivo proliferation and activation. The V H repertoire demonstrated strong oligoclonality with extensive interconnectivity among the 5 subsets and switched memory B cells. Transcriptome analysis showed separation of CD19 + and CD19 – subsets that included pathways such as cell cycle, hypoxia, TNF-α, and unfolded protein response. They also demonstrated similar long-term in vitro survival after 48 days. In summary, vaccine-induced ASCs with different surface markers (CD19 and CD138) are derived from shared proliferative precursors yet express distinctive transcriptomes. Equal survival indicates that all ASC compartments are endowed with long-lived potential. Accordingly, in vivo survival of peripheral long-lived plasma cells may be determined in part by their homing and residence in the BM microniche.

19 November 2018 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
ARAlexander F. Rosenberg
Alexander F. Rosenberg
CFChristopher Fucile
Christopher Fucile
RWRobert J. White
Robert J. White
MTMelissa Trayhan
Melissa Trayhan
SFSamir Farooq
Samir Farooq
MZMartin S. Zand
Martin S. Zand
To characterize the regional and national variation in prescribing patterns in the Medicare Part D program using dimensional reduction visualization methods. Using publicly available Medicare Part D claims data, we identified and visualized regional and national provider prescribing profile variation with unsupervised clustering and t-distributed stochastic neighbor embedding (t-SNE) dimensional reduction techniques. Additionally, we examined differences between regionally representative prescribing patterns for major metropolitan areas. Distributions of prescribing volume and medication diversity were highly skewed among over 800,000 Medicare Part D providers. Medical specialties had characteristic prescribing patterns. Although the number of Medicare providers in each state was highly correlated with the number of Medicare Part D enrollees, some states were enriched for providers with > 10,000 prescription claims annually. Dimension-reduction, hierarchical clustering and t-SNE visualization of drug- or drug-class prescribing patterns revealed that providers cluster strongly based on specialty and sub-specialty, with large regional variations in prescribing patterns. Major metropolitan areas had distinct prescribing patterns that tended to group by major geographical divisions. This work demonstrates that unsupervised clustering, dimension-reduction and t-SNE visualization can be used to analyze and visualize variation in provider prescribing patterns on a national level across thousands of medications, revealing substantial prescribing variation both between and within specialties, regionally, and between major metropolitan areas. These methods offer an alternative system-wide and pattern-centric view of such data for hypothesis generation, visualization, and pattern identification.

11 April 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
PTPoulami Basu Thakur
Poulami Basu Thakur
ALAbagail R. Long
Abagail R. Long
BNBenjamin J. Nelson
Benjamin J. Nelson
RKRanjit Kumar
Ranjit Kumar
ARAlexander F. Rosenberg
Alexander F. Rosenberg
MGMichael Jeffrey Gray
Michael Jeffrey Gray
Inflammatory diseases of the gut are associated with increased intestinal oxygen concentrations and high levels of inflammatory oxidants, including hydrogen peroxide (H 2 O 2 ) and hypochlorous acid (HOCl), which are antimicrobial compounds produced by the innate immune system. This contributes to dysbiotic changes in the gut microbiome, including increased populations of pro-inflammatory enterobacteria ( Escherichia coli and related species) and decreased levels of health-associated anaerobic Firmicutes and Bacteroidetes. The pathways for H 2 O 2 and HOCl resistance in E. coli have been well-studied, but little is known about how commensal and probiotic bacteria respond to inflammatory oxidants. In this work, we have characterized the transcriptomic response of the anti-inflammatory, gut-colonizing Gram-positive probiotic Lactobacillus reuteri to both H 2 O 2 and HOCl. L. reuteri mounts distinct responses to each of these stressors, and both gene expression and survival were strongly affected by the presence or absence of oxygen. Oxidative stress response in L. reuteri required several factors not found in enterobacteria, including the small heat shock protein Lo18, polyphosphate kinase 2, and RsiR, an L. reuteri -specific regulator of anti-inflammatory mechanisms. These results raise the intriguing possibility of developing treatments for inflammatory gut diseases that could sensitize pro-inflammatory enterobacteria to killing by the immune system while sparing anti-inflammatory, health-associated species. IMPORTANCE: It is becoming increasingly clear that effective treatment of inflammatory gut diseases will require modulation of the gut microbiota. Preventing pro-inflammatory bacteria from blooming while also preserving anti-inflammatory and commensal species is a considerable challenge, but our results suggest that it may be possible to take advantage of differences in the way different species of gut bacteria resist inflammatory oxidants to accomplish this goal.

21 February 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
EZEsther C. Zumaquero
Esther C. Zumaquero
SSSara L. Stone
Sara L. Stone
CSChristopher Scharer
Christopher Scharer
SJScott A. Jenks
Scott A. Jenks
ANAnoma Nellore
Anoma Nellore
FLFrances E. Lund
Frances E. Lund
Although B cells expressing the IFNγR or the IFNγ-inducible transcription factor T-bet drive autoimmunity in Systemic Lupus Erythematosus (SLE)-prone mouse models, the role for IFNγ signaling in human antibody responses is unknown. We show that elevated levels of IFNγ in SLE patients correlate with expansion of the T-bet expressing IgD neg CD27 neg CD11c + CXCR5 neg (DN2) pre-antibody secreting cell (pre-ASC) subset. We demonstrate that naïve B cells form T-bet hi pre-ASCs following stimulation with either Th1 cells or with IFNγ, IL-2, anti-Ig and TLR7/8 ligand and that IL-21 dependent ASC formation is significantly enhanced by IFNγ or IFNγ-producing T cells. IFNγ promotes ASC development by synergizing with IL-2 and TLR7/8 ligands to induce genome-wide epigenetic reprogramming of B cells, which results in increased chromatin accessibility surrounding IRF4 and BLIMP1 binding motifs and epigenetic remodeling of IL21R and PRDM1 loci. Finally, we show that IFNγ signals poise B cells to differentiate by increasing their responsiveness to IL-21.

3 September 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
MCMiranda Curtiss
Miranda Curtiss
NBNatalia Ballesteros Benavides
Natalia Ballesteros Benavides
ARAlexander F. Rosenberg
Alexander F. Rosenberg
CSChristopher Scharer
Christopher Scharer
BRBeatriz León Ruiz
Beatriz León Ruiz
FLFrances E. Lund
Frances E. Lund
Background/Objectives: We previously demonstrated that dendritic cell (DC) expression of CXCR5 is required for TH2 priming in mice infected with the helminth Heligmosomoides polygyrus (Hp). In this manuscript we examined how CXCR5 controls DC mediated CD4 T helper 2 cell (TH2) development. Methods: We used in vitro TH2 priming assays, RNA-seq analyses and in vivo Hp infection mouse models to identify roles for the CXCR5-expressing DCs in TH2 development. Results: We showed that migratory conventional type 2 dendritic cells (cDC2) express CXCR5 and that deletion of Cxcr5 prevents migratory DC priming of TH2 cells in vitro while overexpression of CXCR5 enhances migratory DC priming of TH2 cells in vitro. To understand how CXCR5 facilitates the TH2 priming capabilities of migratory cDC2 cells, we performed RNAseq analysis on wildtype and Cxcr5−/− DC subsets isolated from msLN of Hp-infected mice. We observed that CXCR5 expression specifically by the migratory cDC2 subset promoted a pro-proliferative transcriptional program in cDC2 cells and was required for cDC2 cell accumulation in the msLN following Hp infection. We demonstrated that CXCR5 expression specifically by cDC2 cells was necessary for upregulation of Chitinase 3-like-1 (Chi3l1), which encodes a secreted protein (Chi3l1) that regulates allergic TH2 responses. We showed that addition of recombinant Chi3l1 protein to in vitro TH2 priming cultures enhanced TH2 development and that deletion of Chi3l1 specifically in DCs resulted in fewer cDC2 cells and decreased TH2 development in vivo following Hp infection. Conclusions: CXCR5 expressed by cDC2 cells is required for induction of Chi3l1, which in turn promotes the TH2 priming capacity of these DCs. These findings provide insight into the actions of CXCR5 and Chi3l1 in helminth infection.